In addition, the expression of miR-146a is increased in the peripheral blood mononuclear cells (PBMCs) of RA patients, but the two targets of miR-146a, TRAF6 and IRAK1, express similar levels between RA patients and control individuals [89]. This evidence concerns the gene TRAF6 and rheumatoid arthritis.